Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
04/2001
04/11/2001EP1089964A1 Hydrazine derivatives
04/11/2001EP1089958A2 Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha,beta-unsaturated carboxylic acid and aldehyde compounds
04/11/2001CN1291192A 5,6,7-trino-4,8-inter-m-phenylene PGI2 derivative and drugs containing the same
04/11/2001CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
04/11/2001CN1291100A Cyclopentane Heptan (ene) oic acid, 2-hetero arylakenyl derivatives and therapeutic agents
04/11/2001CN1290703A New metal protease inhibitors, its preparing method and their medicinal composition containing them
04/11/2001CN1290700A Phenyl piperazine derivatives
04/11/2001CN1290685A Continously hydrogen adding method
04/11/2001CN1064356C New piperazine, piperidine and 1,2,5,6-tetrahydropyridine compounds process for preparation thereof, and pharmaceutical composition containing them
04/11/2001CN1064349C Novel tricyclic amide, its preparing method and medicinal composition
04/10/2001US6215016 Hematopoietic agents; preventing cytopenia
04/10/2001US6214994 Treatment of neoplastic diseases, bacterial or fungal infections, and preventing or decreasing production of phosphorylated paired helical filament (phf) epitopes associated with alzheimer's disease
04/10/2001US6214883 Benzamidoxime prodrugs as antipneumocystic agents
04/10/2001US6214880 Lowering plasma cholesterol levels and inhibiting abnormal cell proliferation with said compound; treatment of cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia
04/10/2001US6214877 Antidiabetic agents; modulator of glucose concentration
04/10/2001US6214869 Heterocyclic cis cyclopropane derivatives as melatonergic agents
04/10/2001US6214859 Psychological disorders; alzheimer's disorders; parkinson'sdisorders
04/10/2001US6214835 Dihalopropene compounds insecticides containing them as active ingredients, and intermediates for their production
04/10/2001US6214481 Organic blue-emitting layer sandwiched between two electrodes
04/10/2001CA2077252C Methods of making ureas and guanidines, and intermediates therefor
04/05/2001WO2001023372A1 Anti-drug resistant strain agents and antichlamydia agents
04/05/2001WO2001023354A2 Trifluoromethyl-substituted spirocyclic ketoenols and use thereof as pesticides and herbicides
04/05/2001WO2001023352A2 Preparation of sulfonyl imine compounds
04/05/2001WO2001023347A1 Novel aromatic compounds
04/05/2001DE19947457A1 New 2'-aminomethyl-biphenyl-2-carboxamide derivatives, are potassium channel blockers especially useful for treating re-entry or supraventricular arrhythmia or atrial fibrillation or flutter
04/05/2001DE19946625A1 Trifluormethylsubstituierte spirocyclische Ketoenole Trifluoromethyl-substituted spirocyclic ketoenols
04/05/2001CA2384501A1 Trifluoromethyl-substituted spirocyclic ketoenols
04/05/2001CA2378028A1 Preparation of sulfonyl imine compounds
04/04/2001EP1088820A1 Process for the preparation of 3-hydroxytetrahydrofuran
04/04/2001EP1087961A1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
04/04/2001EP1087957A1 Autoinducer compounds
04/04/2001EP1087956A2 A reference compound for use in the analysis of levosimendan batches
04/04/2001EP1087943A1 Therapeutic biaryl derivatives
04/04/2001EP1087938A1 Inhibitors of neuraminidases
04/04/2001EP1087926A2 Analytic substrates and antioxidative agents
04/04/2001CN1290266A Benzofuran-4-carboxamides and their therapeutical use
04/04/2001CN1290249A Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof
04/04/2001CN1290247A Process and intermediates useful to make antifolates
04/04/2001CN1064041C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for production of pharmaceutical preparations, and pharmaceutical preparations containing them
04/03/2001US6211385 Process for preparing substituted benzo[1,2-G]-chrome-3-ene, benzo[1,2-G]-thiochrom-3-ene and benzo[1,2-G]-1,2-dihydroquinoline derivatives
04/03/2001US6211240 O-benzyl oxime ether derivatives and their use as pesticides
04/03/2001US6211234 Substituted phenyl compounds
04/03/2001US6211203 Respiratory system disorders, antiinflammatory agents, enzyme inhibitors
04/03/2001US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction
04/03/2001US6211176 α- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
03/2001
03/30/2001CA2321322A1 Savoury flavour comprising 2-methylfuran-3-thiol and/or a derivative and methylenedithiol and/or derivative
03/29/2001WO2001021607A2 Process for the preparation of mycophenolic acid and derivatives thereof
03/29/2001WO2001021606A1 Liquid crystal compounds
03/29/2001WO2001021605A2 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds and use of said compounds in therapy, cosmetics and food
03/29/2001WO2001021584A1 Tyrosine derivatives
03/29/2001WO2001021583A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient
03/29/2001WO2001021577A2 Melanin concentrating hormone antagonist
03/29/2001WO2001021160A2 Carboxymide and aniline derivatives as selective inhibitors of pathogens
03/29/2001WO2001002350A3 Novel amino sulfonamides and amido sulfonamides as antiviral agents
03/29/2001WO2000073294A3 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
03/29/2001WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's)
03/29/2001CA2386474A1 Melanin concentrating hormone antagonist
03/29/2001CA2385317A1 Process for the preparation of mycophenolic acid and derivatives thereof
03/28/2001EP1086942A1 Optically active alcohols and processes for the preparation thereof
03/28/2001EP1086096A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
03/28/2001EP1086090A1 Composition for the treatment of cancer and colitis ulcerosa as well as the use of a titanium complex and a zinc salt for the preparation of the composition
03/28/2001EP1086089A1 Method for producing butyrolactones
03/28/2001EP1086080A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
03/28/2001EP1086076A1 Sulfonamide inhibitors of aspartyl protease
03/28/2001EP1086072A1 Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof
03/28/2001EP1086063A1 Novel potassium channel drugs and their uses
03/28/2001EP1085845A2 Multibinding inhibitors of cyclooxygenase-2
03/28/2001EP1035772A4 Fungicidal compositions and methods, and compounds and methods for the preparation thereof
03/28/2001CN1289329A Process for the preparation of SOTOLON
03/28/2001CN1289321A Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
03/28/2001CN1289248A Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
03/27/2001US6208719 Method and apparatus for telecommunications having automatic network adaptations and silent mode operations
03/27/2001US6207841 Bisphenol derivative and its manufacturing method
03/27/2001US6207839 Process for preparing compositions useful as intermediates for preparing lubricating oil and fuel additives
03/27/2001US6207703 Mucoadministering to airways formulation comprising antifungal agent to reduce or eliminate symptoms of asthma
03/27/2001US6207697 Amidinyl-substituted rings; anticoagulants; thromboembolic disorders; antiischemic and antiinflammatory agents; strokes; serine protease inhibitors
03/27/2001US6207665 To treat inflammatory disorders in humans
03/22/2001WO2001019811A2 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv
03/22/2001WO2001019809A1 Tryptase inhibitors
03/22/2001WO2001019808A1 Chemical compounds and compositions and their use as cathepsin s inhibitors
03/22/2001WO2001019796A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors
03/22/2001WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties
03/22/2001WO2001019770A2 Rxr modulators with improved pharmacologic profile
03/22/2001WO2000061134A8 Antimicrobial agents
03/22/2001CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors
03/22/2001CA2384763A1 Tryptase inhibitors
03/22/2001CA2383565A1 Rxr modulators with improved pharmacologic profile
03/21/2001EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/21/2001EP1085009A1 Indan derivatives
03/21/2001EP1084115A1 Method for producing phthalic anhydride
03/21/2001CN1288459A Organic nitrile derivatives and their use as pesticides
03/21/2001CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion
03/21/2001CN1063430C Ethanolamine derivatives
03/20/2001US6204417 Method for producing aliphatic alcohols
03/20/2001US6204399 Process and arrangement for producing tetrahydrofuran
03/20/2001US6204395 From maleic anhydride in vapor phase; catalytic hydrogenation
03/20/2001US6204394 Reacting halo-phthalic anhydride witha carboante in a solvent with a phase transfer catalyst
03/20/2001US6204293 Inhibitors of protein isoprenyl transferases
03/20/2001US6204292 Bicyclic metabotropic glutamate receptor ligands
03/20/2001US6204222 Substituted cyclohexene-1,2-dicarboxylic acid derivatives and intermediates for their preparation